Messmore HL - Search Results

1

Heparin-associated thrombocytopenia in maintenance hemodialysis patients.

Leehey DJ, Kanak RJ, Messmore HL, Nawab ZM, Popli S, Ing TS. Leehey DJ, et al. Among authors: messmore hl. Int J Artif Organs. 1987 Nov;10(6):390-2. Int J Artif Organs. 1987. PMID: 3443522

2

Benefit-risk assessment of treatments for heparin-induced thrombocytopenia.

Messmore H, Jeske W, Wehrmacher W, Walenga J. Messmore H, et al. Drug Saf. 2003;26(9):625-41. doi: 10.2165/00002018-200326090-00003. Drug Saf. 2003. PMID: 12814331 Review.

3

Simple scoring system for early management of heparin-induced thrombocytopenia.

Messmore HL, Fabbrini N, Bird ML, Choudhury AM, Cerejo M, Prechel M, Jeske WP, Siddiqui A, Thethi I, Wehrmacher WH, Walenga JM. Messmore HL, et al. Clin Appl Thromb Hemost. 2011 Apr;17(2):197-201. doi: 10.1177/1076029610387126. Epub 2010 Dec 15. Clin Appl Thromb Hemost. 2011. PMID: 21159704 Free article.

4

Successful treatment of heparin-associated thrombocytopenia and thrombosis using Hirulog.

Chamberlin JR, Lewis B, Leya F, Wallis D, Messmore H, Hoppensteadt D, Walenga JM, Moran S, Fareed J, McKiernan T. Chamberlin JR, et al. Can J Cardiol. 1995 Jun;11(6):511-4. Can J Cardiol. 1995. PMID: 7780873

5

Heparin-induced thrombocytopenia: historical review.

Messmore HL Jr. Messmore HL Jr. Clin Appl Thromb Hemost. 1999 Oct;5 Suppl 1:S2-6. doi: 10.1177/10760296990050s102. Clin Appl Thromb Hemost. 1999. PMID: 10726029 Free article.

6

Interaction of heparinoids with platelets: comparison with heparin and low molecular weight heparins.

Messmore HL, Griffin B, Koza M, Seghatchian J, Fareed J, Coyne E. Messmore HL, et al. Semin Thromb Hemost. 1991;17 Suppl 1:57-9. Semin Thromb Hemost. 1991. PMID: 1712512 Review.

7

In vitro studies of the interaction of heparin, low molecular weight heparin and heparinoids with platelets.

Messmore HL Jr, Griffin B, Fareed J, Coyne E, Seghatchian J. Messmore HL Jr, et al. Ann N Y Acad Sci. 1989;556:217-32. doi: 10.1111/j.1749-6632.1989.tb22505.x. Ann N Y Acad Sci. 1989. PMID: 2472085

8

Inadequacy of current prevention strategies for heparin-induced thrombocytopenia.

Wallis DE, Lewis BE, Messmore HL, Pifarre R, Walenga JM. Wallis DE, et al. Among authors: messmore hl. Clin Appl Thromb Hemost. 1999 Oct;5 Suppl 1:S16-20. doi: 10.1177/10760296990050s104. Clin Appl Thromb Hemost. 1999. PMID: 10726031 Free article. Review.

9

Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia.

Walenga JM, Jeske WP, Messmore HL. Walenga JM, et al. Among authors: messmore hl. J Thromb Thrombolysis. 2000 Nov;10 Suppl 1:13-20. doi: 10.1023/a:1027372901367. J Thromb Thrombolysis. 2000. PMID: 11155190 Review.

10

Ethylenediaminetetraacetic acid (EDTA) in heparin.

Coyne E, Messmore HL, Walenga JM, Fareed J, Wehrmacher WH. Coyne E, et al. Among authors: messmore hl. Thromb Res. 1998 Jun 1;90(5):245-6. doi: 10.1016/s0049-3848(98)00063-2. Thromb Res. 1998. PMID: 9694247 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters